Review Summary
Amble Health is a telehealth platform that provides doctor-prescribed GLP-1 therapies (including semaglutide and tirzepatide) fully online — no insurance required. They emphasize “no membership fees, same price for every dose, free expedited delivery,” and a pricing model starting at $135/month for GLP-1 injections. They operate in all 50 U.S. states and present simplified intake and fulfillment via partner pharmacies.
Something to keep in mind: Because of their low price and simplified model, quality control, fulfillment reliability, or pharmacy sourcing may have hidden variability (user reports variegated experiences)
See what reviewers are saying
There are no reviews yet. Be the first one to write one.
Leave a Review
Pros & Cons
✔️ No membership fees — “Same price, every dose” is explicitly stated on their site
✔️ Low starting cost — pricing from $135/month for GLP-1 injections as listed on their site
✔️ Fast and streamlined process with free expedited shipping and online care across all states
❌ Some user complaints about orders not being delivered or delayed (BBB complaints)
❌ Potential legal / regulatory risk: Novo Nordisk has alleged that Amble sells “unapproved compounded drugs” containing semaglutide.
Starting Price
135
Turnaround Time
7-21 Days
Refund Policy
I did not find a clearly published refund or guarantee policy on Amble’s site. Some user complaints suggest difficulty with refunds or order non-delivery (BBB complaints).
How It Works
Choose plan / dosage goal via their “Start Online Visit” workflow > Complete intake / medical questionnaire online > Licensed provider evaluates and authorizes prescription > Prescription is fulfilled via pharmacy partner and shipped (expedited) to patient
Best For
Patients who want a low-cost, no-membership, telehealth GLP-1 injection option and are willing to accept higher risk on delivery, pharmacy consistency, or regulatory unpredictability.
Unique Selling Points
Amble differentiates itself with no membership fees, uniform pricing across doses, and a very low advertised entry point ($135/month), plus online, nationwide access.